share_log

HC Wainwright & Co. Maintains Buy on Microbot Medical, Lowers Price Target to $8

HC Wainwright & Co. Maintains Buy on Microbot Medical, Lowers Price Target to $8

HC Wainwright & Co.维持对Microbot Medical的买入,将目标价下调至8美元
Benzinga ·  2023/05/09 05:37

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $20 to $8.

HC Wainwright & Co. 分析师拉古拉姆·塞尔瓦拉朱维持Microbot Medical(纳斯达克股票代码:MBOT)的买入,并将目标股价从20美元下调至8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发